The first concern is that the consultation seeks to link this proposed guidance with the GPhC’s Standards for registered pharmacies but without any proposed mechanism for how this would be monitored by GPhC Inspectors. The Inspection decision-making framework currently used by inspectors does not even once mention Equality, Diversity, or Inclusiveness (EDI) within the document.
The PDA’s second concern is that the document suggests to pharmacy owners that they don’t need to undertake a specific risk assessment at every pharmacy premises. The PDA does not accept that a generic risk assessment would be valid and contends that every pharmacy premises is unique and thus needs its own unique assessment of risk.
Read the PDA’s full response here
Read the consultation document here
The consultation ran from 7 April 2020 to 6 June 2021.
Learn more
Not yet a PDA member?
If you have not yet joined the PDA, we encourage you to join today and ask your colleagues to do the same.
Membership is FREE to pharmacy students, trainee pharmacists and for the first three months of being newly qualified.
Read about our key member benefits here.